Anadolu Medical Center
| トルコ | オーストリア | スペイン | |
| 定位放射線手術 | から $4,500 | から $17,000 | から $12,000 |
ムスタファ・ソラク医師は、ヒサール・ホスピタル・インターコンチネンタルにおいて、高度な治療技術を用いて肺癌および頭頸部癌を含む複雑な悪性腫瘍の治療を専門としています。
Prof. Dr. Ahmet Hilmi Kaya is a professor of neurosurgery at Anadolu Medical Center in Gebze, Turkey. He earned his MD from Istanbul University Cerrahpaşa (English program). He completed his neurosurgery residency there from 1996 to 2003. He became a professor in 2015. He also completed observerships at Maastricht University in 2007 and 2009.
His clinical focus includes functional and stereotactic neurosurgery, including deep brain stimulation (DBS) for Parkinson’s disease and essential tremor. He also treats spinal tumors and spinal stenosis and performs spinal instrumentation. He manages skull base and brain tumors. He performs vascular surgery of the central nervous system.
Achievements include leading a Parkinson’s research project at Ondokuz Mayıs University (BAP, Project No. T.597, 2008). He supervised a neurosurgery thesis in 2008. His awards include third place at the 2nd National Congress of the Society of Neurosurgery in 2006, the Turkish Neurosurgical Society Overseas Scholarship in 2008, and the Aysima Altınok Thesis Award in 2009. Several of his papers ranked at the 22nd and 23rd Turkish Neurosurgical Society Scientific Congresses in 2008 and 2009. He is a member of the Turkish Neurosurgical Society and the Turkish Medical Association.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Stereotaxic radiosurgery in Turkey treats malignant brain metastases, gliomas, and benign tumors like meningiomas or acoustic neuromas. This non-invasive radiation also targets vascular arteriovenous malformations and functional disorders, including trigeminal neuralgia and tremors, using advanced Gamma Knife and CyberKnife technologies at Joint Commission International-accredited centers.
Bookimed Expert Insight: Top Turkish oncology hubs like Anadolu Medical Center and Memorial Şişli Hospital offer a distinct clinical advantage by integrating Johns Hopkins Hospital protocols and multi-disciplinary tumor boards. While many global clinics offer only one technology, centers in Istanbul often provide both Gamma Knife and CyberKnife. This allowing surgeons like Prof. Dr. Salih Murat Imer to select the specific tool that best suits a tumor's shape and location.
Patient Consensus: Patients value how these 1-to-3 day outpatient procedures avoid the risks of craniotomy. Those seeking relief from trigeminal neuralgia frequently report significant improvement within 6 months of treatment.
Stereotaxic radiosurgery in Turkey is a non-invasive, bloodless procedure with high success rates. Common side effects include temporary headaches, nausea, and localized scalp irritation. Rare but serious risks include brain swelling or radiation necrosis, which specialist teams manage using advanced technologies like Gamma Knife and TrueBeam STx.
Bookimed Expert Insight: Data from leading Istanbul centers like Anadolu Medical Center shows that specialized coordination prevents common post-op hurdles. While Turkish clinics match global technical standards, the 30-year expertise of surgeons like Dr. Salih Murat Imer is the real safety differentiator. Patients should proactively schedule follow-up MRIs in their home country, as long-term monitoring for radiation necrosis is vital for procedures involving brain metastases or meningiomas.
Patient Consensus: Many patients report the first three days are the hardest due to intense headaches. Most emphasize that packing prescribed pain relief and staying ahead of steroid schedules makes the recovery `manageable and smooth.`
Stereotaxic radiosurgery is highly suitable for children and elderly patients due to its non-invasive nature and precision. This outpatient procedure avoids general anesthesia risks for seniors with co-morbidities and minimizes radiation exposure to developing brain tissue in pediatric cases using Gamma Knife or CyberKnife technologies.
Bookimed Expert Insight: Turkish centers like Medipol Mega University Hospital are specifically recognized for pediatric cancer excellence. Data shows these high-volume clinics often utilize Leksell Gamma Knife Icon, which allows frameless treatment. This is a major advantage for children as it may eliminate the need for invasive head frames.
Patient Consensus: Parents report successful tumor stabilization in children without chemotherapy. Elderly patients appreciate the ability to drive home the next day, avoiding traditional brain surgery risks.
Turkey offers stereotactic radiosurgery (SRS) at 92% lower costs than the United States using identical technologies like Gamma Knife and CyberKnife. Patients receive treatment from board-certified neurosurgeons at JCI-accredited facilities in Istanbul, such as Anadolu Medical Center and Memorial Şişli Hospital, within days of inquiry.
Bookimed Expert Insight: While many choose Turkey for the 94% savings, the real advantage is the affiliation with US institutions. For example, Anadolu Medical Center is affiliated with Johns Hopkins Medicine, meaning patients access American-standard protocols and TrueBeam STx technology at a fraction of the cost found in Baltimore or New York.
Patient Consensus: Patients report that the 24-48 hour recovery period allows them to combine advanced medical treatment with light sightseeing in Istanbul. Most value the seamless logistics, noting that 24/7 coordinators and dedicated drivers eliminate the stress of navigating a foreign healthcare system.